Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 12, 2008, Pages 5295-5306

  Ng, John ^a   Coroneo, Minas T ^b   Wakefield, Denis ^a   Di Girolamo, Nick ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; LIPOCORTIN 5;

ADULT; AGED; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; EYE TUMOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; OCULAR SURFACE SQUAMOUS NEOPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET B RADIATION; UPREGULATION; ZYMOGRAPHY; CARCINOMA IN SITU; CELL SURVIVAL; CONJUNCTIVA; CONJUNCTIVA TUMOR; ENZYME IMMUNOASSAY; ENZYMOLOGY; EPITHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RADIATION EXPOSURE; TUMOR CELL CULTURE; ULTRAVIOLET RADIATION;

ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A5; APOPTOSIS; CARCINOMA IN SITU; CELL SURVIVAL; CONJUNCTIVA; CONJUNCTIVAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 58149265650     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1988     Document Type: Article

References (62)

1. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429-450.
2. Mahoney MC, Burnett WS, Majerovics A, Tanenbaum H. The epidemiology of ophthalmic malignancies in New York State. Ophthalmology. 1990;97:1143-1147. (Pubitemid 20291765)
3. Lee GA, Hirst LW. Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane: a 10-year survey. Arch Ophthalmol. 1992;110:525-527.
4. Newton R, Ferlay J, Reeves G, Beral V, Parkin DM. Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet. 1996;347:1450-1451. (Pubitemid 26161209)
5. Jaworski A, Wolffsohn JS, Napper GA. Detection, aetiology and management of conjunctival intraepithelial neoplasia. Ophthalmic Physiol Opt. 2000;20:371-380. (Pubitemid 30624213)
6. Tornesello ML, Duraturo ML, Waddell KM, et al. Evaluating the role of human papillomaviruses in conjunctival neoplasia. Br J Cancer. 2006;94:446-449. (Pubitemid 43237568)
7. Scott IU, Karp CL, Nuovo GJ. Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. Ophthalmology. 2002;109:542-547. (Pubitemid 34184924)
8. Mahomed A, Chetty R. Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia. Arch Ophthalmol. 2002;120:554-558. (Pubitemid 34496605)
9. McKelvie PA, Daniell M, McNab A, Loughnan M, Santamaria JD. Squamous cell carcinoma of the conjunctiva: a series of 26 cases. Br J Ophthalmol. 2002;86:168-173. (Pubitemid 34127541)
10. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol. 2001;63:8-18.
11. El-Abaseri TB, Putta S, Hansen LA. Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor. Carcinogenesis. 2006;27:225-231. (Pubitemid 43159873)
12. Di Girolamo N, Coroneo M, Wakefield D. Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation. Am J Pathol. 2005;167:489-503. (Pubitemid 43026104)
13. Derijard B, Hibi M, Wu IH, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994;76:1025-1037. (Pubitemid 24106383)
14. Jung SM, Lin HC, Chu PH, et al. Expression of cell cycle-regulatory proteins, MIB-1, p16, p53, and p63, in squamous cell carcinoma of conjunctiva: not associated with human papillomavirus infection. Virchows Arch. 2006;448:301-305.
15. Auw-Haedrich C, Sundmacher R, Freudenberg N, et al. Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma. Graefes Arch Clin Exp Ophthalmol. 2006;244:96-103. (Pubitemid 43013188)
16. Shepler TR, Prieto VG, Diba R, Neuhaus RW, Shore JW, Esmaeli B. Expression of the epidermal growth factor receptor in conjunctival squamous cell carcinoma. Ophthalmic Plast Reconstr Surg. 2006;22:113-115. (Pubitemid 44474508)
17. Fuller LC, Allen MH, Montesu M, Barker JN, Macdonald DM. Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours. Br J Dermatol. 1996;134:28-32. (Pubitemid 26029660)
18. Scott RA, Dua HS, Joseph A, Haynes R, Snead D, Hand NM. E-Cadherin distribution in normal and dysplastic conjunctival epithelium. Eye. 2002;16:198-200. (Pubitemid 34537702)
19. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161-174. (Pubitemid 37328786)
20. Edwards DR, Beaudry PP, Laing TD, et al. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes Relat Metab Disord. 1996;20(suppl 3):S9-S15. (Pubitemid 26108576)
21. MacNaul KI, Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblasts. J Biol Chem. 1990;265:17238-17245.
22. Di Girolamo N, Coroneo MT, Wakefield D. UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPK-dependent pathway. Invest Ophthalmol Vis Sci. 2003;44:4705-4714. (Pubitemid 37315282)
23. Di Girolamo N, Coroneo MT, Wakefield D. Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci. 2001;42:1963-1968. (Pubitemid 32726025)
24. Di Girolamo N, Wakefield D, Coroneo MT. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci. 2000;41:4142-4149.
25. Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res. 2004;23:195-228. (Pubitemid 38496401)
26. Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol. 1997;150:653-666. (Pubitemid 27073792)
27. Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 2001;22:571-579.
28. Vecchi M, Rudolph-Owen LA, Brown CL, Dempsey PJ, Carpenter G. Tyrosine phosphorylation and proteolysis: pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin. J Biol Chem. 1998;273:20589-20595. (Pubitemid 28377629)
29. Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, Wakefield D. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:671-679. (Pubitemid 30158875)
30. Hettiaratchi A, Hawkins NJ, Ward RL, Hunt JE, Wakefield D, Di Girolamo N. The collagenase (MMP-1) gene promoter polymorphism -1607/2G is associated with favorable prognosis in patients with colorectal cancer. Br J Cancer. 2007;96:783-792. (Pubitemid 46376634)
31. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med. 1996;2:461-462. (Pubitemid 26191919)
32. Di Girolamo N, Tedla N, Kumar RK, et al. Culture and characterisation of epithelial cells from human pterygia. Br J Ophthalmol. 1999;83:1077-1082. (Pubitemid 29433434)
33. Di Girolamo N, Endoh I, Jackson N, et al. Human mast cell-derived gelatinase B (MMP-9) is regulated by inflammatory cytokines: role in cell migration. J Immunol. 2006;177:2638-2650. (Pubitemid 44201023)
34. Ritter LM, Garfield SH, Thorgeirsson UP. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. Biochem Biophys Res Commun. 1999;257:494-499.
35. Kopecky KE, Pugh GW Jr, Hughes DE, Booth GD, Cheville NF. Biological effect of ultraviolet radiation on cattle: bovine ocular squamous cell carcinoma. Am J Vet Res. 1979;40:1783-1788.
36. Anderson DE, Badzioch M. Association between solar radiation and ocular squamous cell carcinoma in cattle. Am J Vet Res. 1991;52:784-788.
37. Fisher GJ, Talwar HS, Lin J, et al. Retinoic acid inhibits induction of c-jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest. 1998;101:1432-1440. (Pubitemid 28145261)
38. Dushku N, Hatcher SL, Albert DM, Reid TW. p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch Ophthalmol. 1999;117:1593-1599. (Pubitemid 30003291)
39. Sachdev NH, Di Girolamo N, Nolan TM, McCluskey PJ, Wakefield D, Coroneo MT. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the human lens: implications for cortical cataract formation. Invest Ophthalmol Vis Sci. 2004;45:4075-4082. (Pubitemid 39411163)
40. Di Girolamo N, Verma MJ, McCluskey PJ, Lloyd A, Wakefield D. Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis. Curr Eye Res. 1996;15:1060-1068. (Pubitemid 26360044)
41. Xue ML, Wakefield D, Willcox MD, et al. Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection. Invest Ophthalmol Vis Sci. 2003;44:2020-2025. (Pubitemid 36520295)
42. Dushku N, John MK, Schultz GS, Reid TW. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol. 2001;119:695-706. (Pubitemid 32417376)
43. Fundyler O, Khanna M, Smoller BR. Metalloproteinase-2 expression correlates with aggressiveness of cutaneous squamous cell carcinomas. Mod Pathol. 2004;17:496-502. (Pubitemid 38868415)
44. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74:111-122. (Pubitemid 27455388)
45. Elliot S, Catanuto P, Stetler-Stevenson W, Cousins SW. Retinal pigment epithelium protection from oxidant-mediated loss of MMP-2 activation requires both MMP-14 and TIMP-2. Invest Ophthalmol Vis Sci. 2006;47:1696-1702. (Pubitemid 46780783)
46. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci. 1994;107:2373-2379. (Pubitemid 24292486)
47. Valente P, Fassina G, Melchiori A, et al. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer. 1998;75:246-253. (Pubitemid 28100066)
48. Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene. 2002;21:2245-2252. (Pubitemid 34311378)
49. Coroneo MT, Muller-Stolzenburg NW, Ho A. Peripheral light focusing by the anterior eye and the ophthalmohelioses. Ophthalmic Surg. 1991;22:705-711.
50. Coroneo MT. Albedo concentration in the anterior eye: a phenomenon that locates some solar diseases. Ophthalmic Surg. 1990;21:60-66.
51. Diffey BL. Solar ultraviolet radiation effects on biological systems. Phys Med Biol. 1991;36:299-328.
52. Sawano A, Takayama S, Matsuda M, Miyawaki A. Lateral propagation of EGF signaling after local stimulation is dependent on receptor density. Dev Cell. 2002;3:245-257.
53. Nolan TM, DiGirolamo N, Sachdev NH, Hampartzoumian T, Coroneo MT, Wakefield D. The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. Am J Pathol. 2003;162:567-574. (Pubitemid 36267863)
54. Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science. 1996;274:1194-1197. (Pubitemid 26389285)
55. El-Abaseri TB, Fuhrman J, Trempus C, Shendrik I, Tennant RW, Hansen LA. Chemoprevention of UV light-induced skin tumorigenesis by inhibition of the epidermal growth factor receptor. Cancer Res. 2005;65:3958-3965. (Pubitemid 40616379)
56. Ranson M. Epidermal growth factor receptor tyrosine kinase inhibitors. Br J Cancer. 2004;90:2250-2255. (Pubitemid 38961885)
57. Triratanachat S, Niruthisard S, Trivijitsilp P, Tresukosol D, Jarurak N. Angiogenesis in cervical intraepithelial neoplasia and early-staged uterine cervical squamous cell carcinoma: clinical significance. Int J Gynecol Cancer. 2006;16:575-580.
58. Aspiotis M, Tsanou E, Gorezis S, et al. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye. 2007;21:1095-1101. (Pubitemid 47263760)
59. Qi JH, Ebrahem Q, Moore N, et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med. 2003;9:407-415. (Pubitemid 36460074)
60. Lee MH, Atkinson S, Murphy G. Identification of the extracellular matrix (ECM) binding motifs of tissue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1. J Biol Chem. 2007;282:6887-6898. (Pubitemid 47100842)
61. Bachman KE, Herman JG, Corn PG, et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res. 1999;59:798-802.
62. Pennie WD, Hegamyer GA, Young MR, Colburn NH. Specific methylation events contribute to the transcriptional repression of the mouse tissue inhibitor of metalloproteinases-3 gene in neoplastic cells. Cell Growth Differ. 1999;10:279-286.